Veloxis
Veloxis is a pharmaceutical company that develops and commercializes therapeutics for organ transplantation and cardiovascular indications.
Business Model:
Revenue: $29.1M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Veloxis Information
Veloxis was acquired by
Asahi Kasei.
The acquisition happend on 2019-11-26.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Amerika Plads 37
City: Kobenhavn
State: zealand
Zip: 2100
Country: DK
Financial Info
Stage:
post ipo debt
Raised Last:
$60M
Raised Total:$60M
Social
Metrics
7,908,316Website Global Rank
617Website Monthly Traffic
Twitter Followers
Description
Veloxis is a pharmaceutical company that develops and commercializes therapeutics for organ transplantation and cardiovascular indications.
Contact Phone:
Contact Email:
Veloxis went public on 10/24/2006 on the Other
Listed Exchange:
Other
IPO Date:
10/24/2006
Ticker Symbol:
VELO
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2018 | Post-IPO Debt | 1 | $60M |
Athyrium Capital Management LP Athyrium Capital Management LP Athyrium Capital Management LP Athyrium Capital Management LP |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
